Cabeza Montilla, Laura Author
Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study
- Jabalera Y.
- Garcia-Pinel B.
- Ortiz R.
- Iglesias G.
- Cabeza L.
- Prados J.
- Jimenez-Lopez C.
- Melguizo C.
Pharmaceutics - 1/8/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.421 (2019)
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Novel MicroRNA Sponges to Specifically Modulate Gene Expression in Colon Cancer Cells
- Rama A.R.
- Perazzoli G.
- Cabeza L.
- Mesas C.
- Quiñonero F.
- García-Pinel B.
- Vélez C.
Nucleic Acid Therapeutics - 1/10/2020
- JCR Impact Factor: 5.486 (2020)
- CiteScore: 9.1 (2020)
- SJR: 2.255 (2020
- SNIP: 1.076 (2020
- JCR 5-year Impact Factor: 4.521
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Nanopartículas Magnéticas en el Diagnóstico y Tratamiento del Cáncer
- Kevin Doello
- Laura Cabeza
- Raul Ortiz
- José Luis Arias Mediano
- Consolación Melguizo
- José Carlos Prados
Actualidad médica - 2015
- Dialnet
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
- Cabeza L.
- Perazzoli G.
- Mesas C.
- Jiménez-Luna C.
- Prados J.
- Rama A.R.
- Melguizo C.
AAPS PHARMSCITECH - 1/7/2020
- JCR Impact Factor: 3.246 (2020)
- JCR 5-year Impact Factor: 3.473
- JCR Categories: PHARMACOLOGY & PHARMACY
Nanomedicine to Overcome Multidrug Resistance Mechanisms in Colon and Pancreatic Cancer: Recent Progress
- Raúl Ortíz
- Francisco Quiñonero
- Beatriz García-Pinel
- Marco Fuel Herrera
- Cristina Mesas
- Laura Cabeza
- Consolación Melguizo Alonso
- Jose Prados
Cancers - 1/04/2021
- JCR Impact Factor: 6.575 (2021)
- JCR 5-year Impact Factor: 6.886
- JCR Categories: ONCOLOGY
- Scopus
- ORCID
- Web of Science
Nanomedical Platform for Drug Delivery in Cancer
- Ortiz, Raul
- Cabeza, Laura
- Leiva, Maria C.
- Jimenez-Lopez, Julia
- Melguizo, Consolacion
- Prados, Jose
Current Organic Chemistry - 28/11/2017
10.2174/2213337203666161018121920 View source
- SJR Quartile: Q3
- JCR Impact Factor: 2.193 (2017)
- JCR 5-year Impact Factor: 1.923
- JCR Categories: CHEMISTRY, ORGANIC
- SJR Categories: Organic Chemistry (Q3)
- ORCID
- Web of Science
Nanoformulations for glioblastoma multiforme: A new hope for treatment
- Ortiz R.
- Cabeza L.
- Perazzoli G.
- Jimenez-Lopez J.
- García-Pinel B.
- Melguizo C.
- Prados J.
Future Medicinal Chemistry - 1/1/2019
- SJR Quartile: Q2
- JCR Impact Factor: 3.607 (2019)
- CiteScore: 5.2 (2020)
- SJR: 0.739 (2019
- SNIP: 0.802 (2019
- JCR 5-year Impact Factor: 4.065
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)
- Scopus
- ORCID
- Web of Science
Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines
- Lorente C.
- Arias J.
- Cabeza L.
- Ortiz R.
- Prados J.
- Melguizo C.
- Delgado Á.
- Clares-Naveros B.
Journal of Pharmacy and Pharmacology - 1/04/2018
- SJR Quartile: Q2
- JCR Impact Factor: 2.39 (2018)
- CiteScore: 5 (2020)
- SJR: 0.568 (2018
- SNIP: 0.79 (2018
- JCR 5-year Impact Factor: 2.728
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q2); Pharmacology (Q3)
- Scopus
- ORCID
- Web of Science
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer
- Clares B.
- Biedma-Ortiz R.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Cabeza L.
- Ortiz R.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS - 1/1/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.245 (2013)
- CiteScore: 9 (2020)
- SJR: 1.566 (2013
- SNIP: 1.721 (2013
- JCR 5-year Impact Factor: 4.737
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
- Oliver J.A.
- Ortiz R.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Caba O.
- Mesas C.
- Melguizo C.
- Prados J.
Journal of Biosciences - 1/12/2020
- JCR Quartile: Q3 (2020)
- JCR Impact Factor: 1.826 (2022)
- Category normalized Impact: 0.383 (2020)
- CiteScore: 2.1 (2020)
- SJR: 0.459 (2020
- SNIP: 0.489 (2020
- JCR 5-year Impact Factor: 2.107
- JCR Categories: BIOLOGY
- Scopus
- ORCID
- Web of Science
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
h index
Scopus: 13
Web of Science: 21
i10 index
Scopus: 18
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador